Global Severe Acute Respiratory Syndrome Coronavirus SARS Nucleic Acid Detection Kit Market Size By Type (Enzyme-Linked ImmunoSorbent Assay, Fluorescence PCR), By Application (Hospital, Clinic), By Re...

The Global Severe Acute Respiratory Syndrome Coronavirus (SARS) Nucleic Acid Detection Kit Market was valued at USD 2.4 billion in 2023 and is projected to reach USD 4.1 billion by 2031, growing at a CAGR of 6.9% during the forecast period from 2023 to 2031. The growing prevalence of infectious diseases, rising public health surveillance, and sustained investment in pandemic preparedness are the primary drivers propelling market growth. SARS nucleic acid detection kits are essential molecular diagnostic tools that enable the rapid identification of SARS-CoV and related coronaviruses, helping control outbreaks and ensuring early treatment intervention.

Drivers

1. Rising Emphasis on Early Disease Detection

Governments and health organizations are focusing on early diagnosis of respiratory pathogens to prevent pandemics and reduce mortality. This drives demand for nucleic acid detection kits that offer high sensitivity and specificity in detecting SARS-CoV strains.

2. Technological Advancements in Molecular Diagnostics

Innovations such as real-time PCR, CRISPR-based diagnostics, and isothermal amplification are improving the speed and accuracy of SARS nucleic acid detection kits, thereby enhancing adoption across both clinical and research settings.

3. Growing Demand for Point-of-Care Testing

The increasing need for rapid, decentralized testing in clinics, airports, and other field settings is fueling demand for portable and easy-to-use nucleic acid detection solutions.

Restraints

1. High Equipment and Kit Costs

The advanced technologies embedded in detection kits, along with the requirement for specialized equipment, pose cost barriers—especially in low-income countries or small-scale healthcare facilities.

2. Stringent Regulatory Approvals

Complex and varied regulatory requirements across regions can delay the commercialization and distribution of new diagnostic kits, affecting market penetration timelines.

Opportunity

1. Integration with Digital Health Infrastructure

The integration of detection kits with cloud-based platforms, mobile health apps, and electronic medical records can improve diagnostic data sharing and pandemic response coordination, presenting significant market opportunities.

2. Expansion in Emerging Markets

Countries across Asia-Pacific, Latin America, and Africa are scaling up disease surveillance infrastructure. This creates a fertile environment for the adoption of advanced diagnostic kits for SARS and related pathogens.

Market by System Type Insights

By system type, the Real-time RT-PCR-based detection kits segment held the dominant market share in 2023. These kits remain the gold standard for their accuracy and reliability in identifying SARS-CoV-1 and SARS-CoV-2 genomes. However, the Isothermal Amplification Technology-based kits segment is projected to witness the highest growth rate through 2031, owing to their utility in point-of-care settings and low-resource environments.

Market by End-use Insights

In 2023, the Hospital and Diagnostic Laboratories segment accounted for over 50% of the total market revenue. These end-users continue to invest heavily in molecular testing infrastructure. The Public Health Agencies and Research Institutions segment is expected to experience robust growth, driven by increased disease surveillance and virology research initiatives globally.

Market by Regional Insights

North America led the global SARS nucleic acid detection kit market in 2023 due to high healthcare expenditure, widespread testing infrastructure, and early adoption of advanced diagnostics. Meanwhile, Asia-Pacific is expected to be the fastest-growing region, supported by large-scale testing programs in populous countries such as China and India, and increasing public-private partnerships aimed at pandemic preparedness.

Competitive Scenario

Key players in the global SARS nucleic acid detection kit market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Qiagen N.V., Abbott Laboratories, Danaher Corporation, PerkinElmer Inc., BGI Group, Seegene Inc., and GenScript Biotech Corporation. These companies are focused on expanding their global footprint through new product launches, regulatory approvals, and strategic collaborations.

Recent Developments:

April 2024: Roche received expanded CE-IVD approval for its next-generation SARS-CoV-2 detection kit, enabling multiplex testing for SARS and influenza strains.

December 2023: Thermo Fisher introduced a portable real-time PCR system designed for field deployment in pandemic hotspots.

June 2023: BGI partnered with several Southeast Asian health ministries to deploy SARS nucleic acid detection platforms in rural testing centers.

Scope of Work – Global Severe Acute Respiratory Syndrome Coronavirus (SARS) Nucleic Acid Detection Kit Market

Report Metric Details

Market Size (2023) USD 2.4 billion

Projected Market Size (2031) USD 4.1 billion

CAGR (2023–2031) 6.9%

Market Segments System Type, End-use, Region

Growth Drivers Early disease detection, tech innovation, PoC demand

Opportunities Emerging markets, digital integration

FAQs

1) What is the current market size of the Global Severe Acute Respiratory Syndrome Coronavirus (SARS) Nucleic Acid Detection Kit Market?

The market size was valued at USD 2.4 billion in 2023.

2) What is the major growth driver of the Global SARS Nucleic Acid Detection Kit Market?

The increasing demand for early detection and molecular testing of infectious respiratory viruses.

3) Which is the largest region during the forecast period in the Global SARS Nucleic Acid Detection Kit Market?

North America dominated in 2023, but Asia-Pacific is expected to grow at the fastest pace through 2031.

4) Which segment accounted for the largest market share in the SARS Nucleic Acid Detection Kit Market?

The Real-time RT-PCR-based detection kits segment led in terms of market share in 2023.

5) Who are the key market players in the Global SARS Nucleic Acid Detection Kit Market?

Key players include Thermo Fisher Scientific, Roche, Qiagen, Bio-Rad, Abbott, Danaher, and BGI Group.

Would you like a visual chart or infographic included for presentation purposes?